372. Targeted Mutagenesis of Ubiquitin-Binding Lysine Residues on the Adeno- Associated Virus (AAV)2 Capsid Improves Its Transduction Efficiency    Molecular.

Slides:



Advertisements
Similar presentations
Jennifer G. Cheung, Krystyna Konopka, Nejat Düzgünes
Advertisements

Volume 20, Issue 2, (February 2012)
Hepatic AAV Gene Transfer and the Immune System: Friends or Foes?
414. A Novel Clinical Severity Scoring Measure in Canine X-Linked Myotubular Myopathy: Results Following Systemic AAV Gene Replacement    Molecular Therapy 
209. Use of Helicobacter pyroli Neutrophil Activating Protein (NAP) as an Immune- Modulatory Agent To Enhance the Efficacy of Oncolytic Adenovirus Therapy.
Volume 3, Issue 6, Pages (June 2001)
446. Gender Differences in the Osteogenic & Chondrogenic Potential of Human Muscle- Derived Stem Cells In Vitro  Alex C. Scibetta, Andrea B. Liebowitz,
Man's Best Friend: Utilizing Naturally Occurring Tumors in Dogs to Improve Chimeric Antigen Receptor T-cell Therapy for Human Cancers  Melinda Mata, Stephen.
Volume 20, Issue 2, Pages (February 2012)
Genome-editing Technologies for Gene and Cell Therapy
627. Non-Invasive, Multimodal Imaging of Microvesicles with Metabolically Biotinylated, Membrane-Bound Gaussia Luciferase    Molecular Therapy  Volume.
162. Stability of Polymer/Plasmid DNA Complexes In Vitro and In Vivo
281. Rapid Generation of Induced Pluripotent Stem Cells (iPSCs) from the Urine of a Patient with Duchenne Muscular Dystrophy    Molecular Therapy  Volume.
Molecular Therapy - Methods & Clinical Development
Direct Conversion of Skin Cells into Blood: Alchemy or Science?
Molecular Therapy  Volume 20, Pages S261-S262 (May 2012) DOI: /S (16)
Evolving Gene Therapy in Primary Immunodeficiency
343. Benchtop DNA Synthesizer: Oligo-Templated Polymerization (OTP)
637. Effect of PEG Grafting Degree on Morphology and Transfection Efficiency of Polycation-g-PEG/DNA Nanoparticles    Molecular Therapy  Volume 20, (May.
A Theranostic “SMART” Aptamer for Targeted Therapy of Prostate Cancer
Chen Ling, Baozheng Li, Wenqin Ma, George Aslanidi, Arun Srivastava
Volume 20, Issue 2, Pages (February 2012)
724. Blood-Derived Endothelial Progenitor Cells Can Be Isolated With a Novel Method of Diluted Whole Blood Incubation with AMD3100-Induced Mobilization.
Molecular Therapy  Volume 20, (May 2012) DOI: /S (16)
Volume 22, Issue 8, Pages (August 2014)
Genome-editing Technologies for Gene and Cell Therapy
Volume 22, Issue 11, Pages (November 2014)
Volume 21, Issue 2, Pages (February 2013)
Molecular Therapy  Volume 20, (May 2012) DOI: /S (16)
Molecular Therapy  Volume 7, Issue 5, (May 2003) DOI: /S (16)
Volume 18, Issue 1, Pages (January 2010)
547. AAV Preparations Contain Contamination from DNA Sequences in Production Plasmids Directly Outside of the ITRs  Mark A. Brimble, Junfang Zhou, Christopher.
847. Eradication of Therapy-Resistant Human Prostate Tumors Using an Ultrasound Guided Site-Specific Cancer Terminator Virus Delivery Approach    Molecular.
Designer Lipids Advance Systemic siRNA Delivery
Donna M. Martin, Yehoash Raphael  Molecular Therapy 
133. Survival with Normal Neurological Development of the Juvenile Lethal Urea Cycle Defect Arginase Deficient Mouse with AAV Gene Therapy    Molecular.
660. Bowel/Bladder Sensation and Control in Patients with Spinal Cord Injury Treated with Human Embryonic Stem Cell Therapy  Geeta Shroff  Molecular Therapy 
68. Site Specific Intra-Placental Gene Transfer Corrects Fetal Growth Restriction in a Novel Mouse Model of Placental Insufficiency (PI)    Molecular.
521. Multiplex Genome Editing of TCR°/CD52 Genes as a Platform for “Off the Shelf” Adoptive T-Cell Immunotherapies    Molecular Therapy  Volume 22, Pages.
Jennifer G. Cheung, Krystyna Konopka, Nejat Düzgünes
Chae-lyul Limg, Yeon-Ju Lee, Sujeong Kim
405. Hindlimb and Forelimb Strength Assessment in a Canine Model of X-Linked Myotubular Myopathy Following AAV-Mediated Gene Replacement    Molecular.
Volume 26, Issue 4, Pages (April 2018)
674. Molecular, Biochemical and Biomechanical Analysis of Articular Cartilage Repaired with Genetically Modified Chondrocytes Expressing Insulin-Like.
Volume 19, Issue 4, Pages (April 2011)
Molecular Therapy  Volume 18, Pages S260-S261 (May 2010) DOI: /S (16)
Mathieu Nonnenmacher, Harm van Bakel, Roger J Hajjar, Thomas Weber 
In This Issue Molecular Therapy Volume 16, Issue 4, (April 2008)
Volume 18, Issue 3, Pages (March 2010)
Volume 26, Issue 2, Pages (February 2018)
521. AAV Immunotherapy Induces Functional Antigen Specific Regulatory T-Cells to a Neuroantigen: A Potential Treatment for MS  Brad E. Hoffman  Molecular.
Effect of Genome Size on AAV Vector Packaging
Molecular Therapy - Methods & Clinical Development
773. Detection of RNA Interference (RNAi) Mediated mRNA Cleavage in Fresh Injected Tumor Tissue from Patients in a Phase I Trial of pbi-shRNA™ Lipoplex.
740. Prevention of Radiation-Induced Lung Injury by Administration of Gene-Modified Mesenchymal Stem Cells    Molecular Therapy  Volume 20, Pages S285-S286.
Molecular Therapy  Volume 21, Pages S247-S248 (May 2013)
Shigeki Yagyu, Malcolm K. Brenner
Volume 15, Issue 7, Pages (July 2007)
86. A Highly Compact Epitope-Based Marker Suicide Gene for Safer and Easier Adoptive T-Cell Gene Therapy    Molecular Therapy  Volume 20, Pages S35-S36.
Volume 24, Issue 1, Pages (January 2016)
297. Minimally Invasive Implantation of Autologous Chondrocytes Transduced with rAAV5-IGF-I Improves Longterm Cartilage Repair in Full-Thickness Chondral.
Zhijian Wu, Aravind Asokan, R. Jude Samulski  Molecular Therapy 
Thomas Gaj, Benjamin E Epstein, David V Schaffer  Molecular Therapy 
10. High-Efficiency Transduction of Primary Human CD34+ Hematopoietic Stem/Progenitor Cells by AAV6 Serotype Vectors: Strategies for Overcoming Donor.
Jingxian Feng, Jiawen Wang, Junsheng Lin, Yong Diao
Shirley Wong, Roderick A. Slavcev
Volume 22, Issue 11, Pages (November 2014)
Hildegard Büning, Arun Srivastava 
Molecular Therapy - Methods & Clinical Development
624. Randomized Phase II Trial of Adjuvant Autologous Tumor Cell Vaccine (FANG™) for High Risk Stage III/IV Ovarian Cancer: Preliminary Results    Molecular.
Presentation transcript:

372. Targeted Mutagenesis of Ubiquitin-Binding Lysine Residues on the Adeno- Associated Virus (AAV)2 Capsid Improves Its Transduction Efficiency    Molecular Therapy  Volume 20, (May 2012) DOI: 10.1016/S1525-0016(16)36176-7 Copyright © 2012 The American Society of Gene & Cell Therapy Terms and Conditions

Figure 1 Transduction efficiency of AAV2 lysine mutants (MOI 2000) in HeLa and HEK293 cells in vitro. The relative fold-increase in gene expression is shown as inserts Molecular Therapy 2012 20, DOI: (10.1016/S1525-0016(16)36176-7) Copyright © 2012 The American Society of Gene & Cell Therapy Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.